期刊
GROWTH HORMONE & IGF RESEARCH
卷 20, 期 3, 页码 270-273出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.ghir.2010.02.004
关键词
GHR; d3/fl polymorphism; TagSNP; Genotyping method
资金
- Swedish Research Council [K2007-55X-11285-13-3, K2008-65p-20758-01]
- Swedish Foundation for Strategic Research
- Swedish federal government
- University of Gothenburg
- Novo Nordisk Scandinavia AB
- Pfizer
Objective: The growth hormone (GH) receptor (GHR) exon 3 deleted/full-length (d3/fl) polymorphism has been suggested to affect GH sensitivity. The conventional genotyping method used for this polymorphism (multiplex PCR with fragment detection by gel electrophoresis) is laborious and requires large amount of DNA template. This has restricted analysis of this polymorphism to small cohorts. Our aim was to evaluate the accuracy of using a tagging single nucleotide polymorphism (tagSNP) as a marker for the d3/fl polymorphism. Design: The d3/fl polymorphism was analyzed using TaqMan SNP genotyping of the tagSNP rs6873545 in 183 patients with adult GB deficiency (GHD). The results were compared to d3/fl genotypes determined by the conventional method. Results: Genotyping success rate for the tagSNP was 100%. Frequency of the d3-allele was 24.0% (d3/d3 7.7%, d3/fl 32.2% and fl/fl 60.1%) and the results from the two different methods were identical. Moreover, three samples previously undetermined when genotyped using the conventional method were successfully analyzed using the tagSNP. Conclusion: The GHR d3/fl polymorphism can be studied by TaqMan SNP genotyping. Use of the tagSNP facilitates investigations of the effects of the d3/fl polymorphism in large cohorts. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据